Cora N. Sternberg, MD, on Prostate Cancer Treatment Findings: Expert Perspective

2017 ESMO Congress
Tweet this page

Cora N. Sternberg, MD, of the San Camillo Forlanini Hospital, summarizes a session on the STAMPEDE and LATITUDE trials, as well as a third trial on docetaxel with androgen suppression for localized prostate cancer patients who relapsed after radical prostatectomy and/or radiotherapy (Abstracts LBA31, 783O, 784O).

Advertisement

Advertisement



Advertisement